November 05, 2019 Vascepa's future could hinge on next week's panel Amarin’s Vascepa is widely expected to receive approval in a huge new patient population. So why has the company not been bought?
May 14, 2019 Price fixing case caps a terrible week for generics Shares in generics firms tumble in the wake of a huge lawsuit in the US alleging industry-wide price fixing, signalling many more years of pain for this sector.
